Background Bronchoalveolar lavage (BAL) is essential in determining the efficacy of novel therapies in alpha-1 antitrypsin deficiency (AATD). These require initial proof-of-concept demonstration that ...

Chi - Submitted regulatory filing for first-in-human clinical study of KRRO-110 in patients with alpha-1 antitrypsin deficiency (AATD) - Formed Clinical Advisory Board (CAB) of leading lung and ...

Charles Schwab Investment Management Inc. lifted its holdings in Beam Therapeutics Inc ... a liver-targeting LNP formulation ...

Sony has announced the second generation Alpha 1 II, its new flagship full-frame camera. According to Sony, the new mirrorless camera combines some of the most requested and beloved features of Sony’s ...

In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...

Chronic obstructive pulmonary disease (COPD), a significant yet often overlooked health issue in Malaysia due to low awareness and understanding, affects a considerable portion of the population, as ...

SAN DIEGO, Nov. 19, 2024 /PRNewswire/ -- Today Sony Electronics Inc. introduces the Alpha 1 II, its new flagship full-frame camera. This mirrorless camera brings together some of the most ...

BNP Paribas Financial Markets raised its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 88.0% during the ...

Historically, clinicians and researchers have a complicated architecture to resolve such issues on Wilson’s disease, hemochromatosis and alpha-1-antitrypsin deficiency, and so on ... revealing its ...